Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Andreoni

Showing results (161-170 of 306) with videos related to

Pageof 31
Sort By:
Antibiotics (Basel, Switzerland)|September 28, 2023
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, ItalyAndrea Di Lorenzo, Laura Campogiani, Marco Iannetta, et al.
Blood|August 15, 2002
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapyMauro Malnati, Francesco Broccolo, Silvia Nozza, et al.
Antiviral Therapy|February 5, 2008
Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutationAndrea Antinori, Maria Paola Trotta, Patrizia Lorenzini, et al.
Current HIV Research|May 14, 2008
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimensEmanuele Nicastri, Lucia Palmisano, Loredana Sarmati, et al.
Human Genomics|September 12, 2020
Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patientsAntonio Novelli, Michela Biancolella, Paola Borgiani, et al.
Heliyon|October 7, 2020
Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patientsFrancesca Amati, Chiara Vancheri, Andrea Latini, et al.
Current HIV Research|October 1, 2015
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected CamerooniansRomina Salpini, Joseph Fokam, Laura Ceccarelli, et al.
Plos One|February 14, 2017
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patientsNicola Gianotti, Alessandro Cozzi-Lepri, Andrea Antinori, et al.
Viruses|May 8, 2020
Merkel Cell Polyomavirus (MCPyV) in the Context of Immunosuppression: Genetic Analysis of Noncoding Control Region (NCCR) Variability among a HIV-1-Positive PopulationCarla Prezioso, Francisco Obregon, Donatella Ambroselli, et al.
Microbiology Spectrum|September 13, 2022
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma ProductionGrazia Alessio, Alessandra Imeneo, Andrea Di Lorenzo, et al.
Pageof 31

Showing results (161-170 of 306) with videos related to

Sort By:
Pageof 31
Antibiotics (Basel, Switzerland)|September 28, 2023
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, ItalyAndrea Di Lorenzo, Laura Campogiani, Marco Iannetta, et al.
Blood|August 15, 2002
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapyMauro Malnati, Francesco Broccolo, Silvia Nozza, et al.
Antiviral Therapy|February 5, 2008
Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutationAndrea Antinori, Maria Paola Trotta, Patrizia Lorenzini, et al.
Current HIV Research|May 14, 2008
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimensEmanuele Nicastri, Lucia Palmisano, Loredana Sarmati, et al.
Human Genomics|September 12, 2020
Analysis of ACE2 genetic variants in 131 Italian SARS-CoV-2-positive patientsAntonio Novelli, Michela Biancolella, Paola Borgiani, et al.
Heliyon|October 7, 2020
Expression profiles of the SARS-CoV-2 host invasion genes in nasopharyngeal and oropharyngeal swabs of COVID-19 patientsFrancesca Amati, Chiara Vancheri, Andrea Latini, et al.
Current HIV Research|October 1, 2015
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected CamerooniansRomina Salpini, Joseph Fokam, Laura Ceccarelli, et al.
Plos One|February 14, 2017
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patientsNicola Gianotti, Alessandro Cozzi-Lepri, Andrea Antinori, et al.
Viruses|May 8, 2020
Merkel Cell Polyomavirus (MCPyV) in the Context of Immunosuppression: Genetic Analysis of Noncoding Control Region (NCCR) Variability among a HIV-1-Positive PopulationCarla Prezioso, Francisco Obregon, Donatella Ambroselli, et al.
Microbiology Spectrum|September 13, 2022
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma ProductionGrazia Alessio, Alessandra Imeneo, Andrea Di Lorenzo, et al.
Pageof 31